Pharmafile Logo
Pharmafocus logo
Advanced Search

constipation

Showing 3 posts of 3 posts found.

astellas_japan_headquarters

Astellas and Ironwood release positive Phase 3 results for constipation drug

January 30, 2017
Research and Development, Sales and Marketing Astellas, Ironwood, constipation

Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …

News
Shire image

Shire earns EMA nod for constipation drug

June 3, 2015
Sales and Marketing EMA, Resolor, Shire, constipation

Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …

News
Daiichi image

AstraZeneca and Daiichi team up for constipation drug

March 19, 2015
Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic

AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025